tm logo
STERLING
Live/Pending
SUSPENSION LETTER - MAILED

mailed

on 11 Oct 2024

Last Applicant/ Owned by

Dudley

Northumberland

GB

NE237QG

Serial Number

98307598 filed on 11th Dec 2023

Registration Number

N/A

Correspondent Address

Laura A. Kees

Laura A. Kees Womble Bond Dickinson (US) LLP

Atlanta, GA 30357

United States

Filing Basis

No Filing Basis

Disclaimer

NO DATA

STERLING

Pharmaceutical research services; pharmaceutical drug development services; chemical research services; pharmaceutical and chemical product development services; pharmaceutical and chemical products design services; testing of pharmaceuticals and chemicals; pharmaceutical and chemical drug development services; scientific research in the nature of conducting clinical trials for others in the field Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Pharmaceutical research services; pharmaceutical drug development services; chemical research services; pharmaceutical and chemical product development services; pharmaceutical and chemical products design services; testing of pharmaceuticals and chemicals; pharmaceutical and chemical drug development services; scientific research in the nature of conducting clinical trials for others in the field of viral, infectious, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical drug and chemical analysis; scientific and technological services, namely, shaping and designing pills, chemical composition analysis, testing, analysis, and evaluation of pharmaceuticals to determine conformity with certification standards; pharmaceutical laboratory research services relating to pharmaceuticals; biological research services; information, advice and consultancy services in relation to the aforesaid services


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [040]
Treatment & Processing of Materials Services


Custom manufacturing in the field of pharmaceuticals and chemicals; Processing of pharmaceuticals and in the nature of chemicals processing of chemical, biochemical and pharmaceutical products for third parties; information, advice and consultancy services in relation to the aforesaid services.


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Pharmaceuticals, namely, psychotropics, antihelmintics, anti-infectives, lipid lowering agents, inducers of erections, induction agents, neuromuscular blocking agents, sedatives, anti-cancer medication, anti-inflammatories, anti-fungals, anti-bacterials, anti-spasmodics, appetite stimulants, bronchodilators, appetite suppressants, anti-convulsives, neuroprotective drugs, anti-anxiety medication, anti-depressants, anti-ischemics, anti-psychotics; pharmaceutical preparations for treating diabetes, ear, nose and throat disorders, epilepsy, genetic disorders, hematological disorders, hormonal disorders, infectious diseases, lymphoma, metabolic disorders, mouth and dental disorders, musculoskeletal disorder, non-malignant disorder, nutritional disorders, pain, rare ophthalmological diseases, rare cancers, rare infectious diseases, rare genetic diseases, rare respiratory diseases, rare central nervous system diseases, rare gastrointestinal diseases, rare immunological diseases, rare cardiovascular diseases, rare dermatological diseases, rare urinary system and sex hormone diseases, rare womens health diseases, and rare ear, nose, and throat diseases; Pharmaceuticals, namely, pharmaceutical preparations and substances for the treatment of viral, infectious, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders for medical or veterinary purposes


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [001]
Chemical Products


Active chemical ingredients for use in the manufacture of pharmaceuticals for treating diabetes, ear, nose and throat disorders, epilepsy, genetic disorders, hematological disorders, hormonal disorders, infectious diseases, lymphoma, metabolic disorders, mouth and dental disorders, musculoskeletal disorder, non-malignant disorder, nutritional disorders, pain, rare ophthalmological diseases, rare cancers, rare infectious diseases, rare genetic diseases, rare respiratory diseases, rare central nervous system diseases, rare gastrointestinal diseases, rare immunological diseases, rare cardiovascular diseases, rare dermatological diseases, rare urinary system and sex hormone diseases, rare womens health diseases, rare ear, nose, and throat diseases, animal health disorders, cardiovascular diseases and disorders, central nervous system disorders, dermatologic disorders, endocrine system disorders, gastrointestinal diseases, genito urinary system and sex hormone imbalances, male health disorders, women's health disorders, mental health disorders, musculoskeletal disorders, renal disorders, cancer, ophthalmic disorders, renal diseases, respiratory diseases, trauma and injury; chemical substances for use in the manufacture of pharmaceuticals for treating diabetes, ear, nose and throat disorders, epilepsy, genetic disorders, hematological disorders, hormonal disorders, infectious diseases, lymphoma, metabolic disorders, mouth and dental disorders, musculoskeletal disorder, non-malignant disorder, nutritional disorders, pain, rare ophthalmological diseases, rare cancers, rare infectious diseases, rare genetic diseases, rare respiratory diseases, rare central nervous system diseases, rare gastrointestinal diseases, rare immunological diseases, rare cardiovascular diseases, rare dermatological diseases, rare urinary system and sex hormone diseases, rare womens health diseases, rare ear, nose, and throat diseases, animal health disorders, cardiovascular diseases and disorders, central nervous system disorders, dermatologic disorders, endocrine system disorders, gastrointestinal diseases, genito urinary system and sex hormone imbalances, male health disorders, women's health disorders, mental health disorders, musculoskeletal disorders, renal disorders, cancer, ophthalmic disorders, renal diseases, respiratory diseases, trauma and injury; chemical materials for use in the manufacture of pharmaceuticals for treating diabetes, ear, nose and throat disorders, epilepsy, genetic disorders, hematological disorders, hormonal disorders, infectious diseases, lymphoma, metabolic disorders, mouth and dental disorders, musculoskeletal disorder, non-malignant disorder, nutritional disorders, pain, rare ophthalmological diseases, rare cancers, rare infectious diseases, rare genetic diseases, rare respiratory diseases, rare central nervous system diseases, rare gastrointestinal diseases, rare immunological diseases, rare cardiovascular diseases, rare dermatological diseases, rare urinary system and sex hormone diseases, rare womens health diseases, rare ear, nose, and throat diseases, animal health disorders, cardiovascular diseases and disorders, central nervous system disorders, dermatologic disorders, endocrine system disorders, gastrointestinal diseases, genito urinary system and sex hormone imbalances, male health disorders, women's health disorders, mental health disorders, musculoskeletal disorders, renal disorders, cancer, ophthalmic disorders, renal diseases, respiratory diseases, trauma and injury; chemical preparations for use in the manufacture of pharmaceuticals for treating diabetes, ear, nose and throat disorders, epilepsy, genetic disorders, hematological disorders, hormonal disorders, infectious diseases, lymphoma, metabolic disorders, mouth and dental disorders, musculoskeletal disorder, non-malignant disorder, nutritional disorders, pain, rare ophthalmological diseases, rare cancers, rare infectious diseases, rare genetic diseases, rare respiratory diseases, rare central nervous system diseases, rare gastrointestinal diseases, rare immunological diseases, rare cardiovascular diseases, rare dermatological diseases, rare urinary system and sex hormone diseases, rare womens health diseases, rare ear, nose, and throat diseases, animal health disorders, cardiovascular diseases and disorders, central nervous system disorders, dermatologic disorders, endocrine system disorders, gastrointestinal diseases, genito urinary system and sex hormone imbalances, male health disorders, women's health disorders, mental health disorders, musculoskeletal disorders, renal disorders, cancer, ophthalmic disorders, renal diseases, respiratory diseases, trauma and injury; chemical additives for use in the manufacture of pharmaceuticals for treating diabetes, ear, nose and throat disorders, epilepsy, genetic disorders, hematological disorders, hormonal disorders, infectious diseases, lymphoma, metabolic disorders, mouth and dental disorders, musculoskeletal disorder, non-malignant disorder, nutritional disorders, pain, rare ophthalmological diseases, rare cancers, rare infectious diseases, rare genetic diseases, rare respiratory diseases, rare central nervous system diseases, rare gastrointestinal diseases, rare immunological diseases, rare cardiovascular diseases, rare dermatological diseases, rare urinary system and sex hormone diseases, rare womens health diseases, rare ear, nose, and throat diseases, animal health disorders, cardiovascular diseases and disorders, central nervous system disorders, dermatologic disorders, endocrine system disorders, gastrointestinal diseases, genito urinary system and sex hormone imbalances, male health disorders, women's health disorders, mental health disorders, musculoskeletal disorders, renal disorders, cancer, ophthalmic disorders, renal diseases, respiratory diseases, trauma and injury; chemical compositions for use in the manufacture of pharmaceuticals for treating diabetes, ear, nose and throat disorders, epilepsy, genetic disorders, hematological disorders, hormonal disorders, infectious diseases, lymphoma, metabolic disorders, mouth and dental disorders, musculoskeletal disorder, non-malignant disorder, nutritional disorders, pain, rare ophthalmological diseases, rare cancers, rare infectious diseases, rare genetic diseases, rare respiratory diseases, rare central nervous system diseases, rare gastrointestinal diseases, rare immunological diseases, rare cardiovascular diseases, rare dermatological diseases, rare urinary system and sex hormone diseases, rare womens health diseases, rare ear, nose, and throat diseases, animal health disorders, cardiovascular diseases and disorders, central nervous system disorders, dermatologic disorders, endocrine system disorders, gastrointestinal diseases, genito urinary system and sex hormone imbalances, male health disorders, women's health disorders, mental health disorders, musculoskeletal disorders, renal disorders, cancer, ophthalmic disorders, renal diseases, respiratory diseases, trauma and injury; none of the aforesaid goods including carbon black


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98307598

Mark Type

No Service Mark

Attorney Docket Number

No S105221 0001

44D Filed

Yes

44D Current

Yes

44E filed

Yes

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.15.02 -

Plain single or multiple line polygons

26.15.13 -

More than one polygon

Legal History


Show more

Status DateAction Taken
11th Oct 2024LETTER OF SUSPENSION E-MAILED
11th Oct 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11th Oct 2024SUSPENSION LETTER WRITTEN
30th Sep 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
30th Sep 2024TEAS/EMAIL CORRESPONDENCE ENTERED
30th Sep 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
17th Jul 2024NON-FINAL ACTION E-MAILED
17th Jul 2024NON-FINAL ACTION WRITTEN
17th Jul 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
10th Jul 2024ASSIGNED TO EXAMINER